SMARCA2 and cancer: However, the molecular studies demonstrating the precise role of SMARCA2 in the regulation of cancer stemness across distinct types of solid tumors are insufficient to make an unequivocal decision on whether SMARCA2 is a negative cancer stemness regulator.